Ji Yan, Li Yusheng, Zhao Zichen, Li Panxing, Xie Yi
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Front Neurosci. 2020 Nov 30;14:582851. doi: 10.3389/fnins.2020.582851. eCollection 2020.
This study aimed to identify the involvement of hydrogen sulfide overproduction in acute brain injury under ischemia/reperfusion and hyperhomocysteinemia.
and experiments were conducted to determine: the effect of sodium hydrosulfide treatment on the human neuroblastoma cell line (SH-SY5Y) under conditions of oxygen and glucose deprivation; the changes of hydrogen sulfide levels, inflammatory factors, energetic metabolism, and mitochondrial function in the brain tissue of rats under either ischemia/reperfusion alone or a combination of ischemia/reperfusion and hyperhomocysteinemia; and the potential mechanism underlying the relationship between homocysteine and these changes through the addition of the related inhibitors. Furthermore, experimental technologies, including western blot, enzyme-linked immunosorbent assay, immunofluorescence, reverse transcription polymerase chain reaction, and flow cytometry, were used.
Our study found that high concentration of sodium hydrosulfide treatment aggravated the decrease in mitochondrial membrane potential, the increase in both mitochondrial permeability transition pore and translocation of cytochrome C, as well as the accumulation of reactive oxygen species in oxygen and glucose deprived SH-SY5Y cells. As a result, neurological deficit appeared in rats with ischemia/reperfusion or ischemia/reperfusion and hyperhomocysteinemia, and a higher water content and larger infarction size of cerebral tissue appeared in rats combined ischemia/reperfusion and hyperhomocysteinemia. Furthermore, alterations in hydrogen sulfide production, inflammatory factors, and mitochondria morphology and function were more evident under the combined ischemia/reperfusion and hyperhomocysteinemia. These changes were, however, alleviated by the addition of inhibitors for CBS, CSE, Hcy, HS, and NF-κB, although at different levels. Finally, we observed a negative relationship between the blockage of: (a) the nuclear factor kappa-B pathway and the levels of cystathionine β-synthase and hydrogen sulfide; and (b) the hydrogen sulfide pathway and the levels of inflammatory factors.
Hydrogen sulfide overproduction and reactive inflammatory response are involved in ischemic cerebral injury under hyperhomocysteinemia. Future studies in this direction are warranted to provide a scientific base for targeted medicine development.
本研究旨在确定硫化氢过量产生在缺血/再灌注及高同型半胱氨酸血症所致急性脑损伤中的作用。
进行实验以确定:硫氢化钠处理对氧糖剥夺条件下人神经母细胞瘤细胞系(SH-SY5Y)的影响;单独缺血/再灌注或缺血/再灌注与高同型半胱氨酸血症联合作用下大鼠脑组织中硫化氢水平、炎症因子、能量代谢及线粒体功能变化;以及通过添加相关抑制剂探讨同型半胱氨酸与这些变化之间关系的潜在机制。此外,还采用了蛋白质免疫印迹法、酶联免疫吸附测定法、免疫荧光法、逆转录聚合酶链反应及流式细胞术等实验技术。
我们的研究发现,高浓度硫氢化钠处理加重了氧糖剥夺的SH-SY5Y细胞中线粒体膜电位降低、线粒体通透性转换孔增加、细胞色素C转位以及活性氧积累。结果,缺血/再灌注或缺血/再灌注与高同型半胱氨酸血症联合作用的大鼠出现神经功能缺损,缺血/再灌注与高同型半胱氨酸血症联合作用的大鼠脑组织含水量更高且梗死面积更大。此外,缺血/再灌注与高同型半胱氨酸血症联合作用下,硫化氢产生、炎症因子以及线粒体形态和功能的改变更为明显。然而,添加胱硫醚β-合酶、胱硫醚γ-裂解酶、同型半胱氨酸、硫化氢及核因子κB抑制剂后,这些变化虽程度不同但均有所减轻。最后,我们观察到:(a)核因子κB通路阻断与胱硫醚β-合酶及硫化氢水平之间呈负相关;(b)硫化氢通路阻断与炎症因子水平之间呈负相关。
高同型半胱氨酸血症时,硫化氢过量产生及反应性炎症反应参与缺血性脑损伤。未来有必要在该方向开展研究,为靶向药物开发提供科学依据。